Literature DB >> 11305057

Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure.

Y Kato1, F Isobe, Y Sasaki, K Kodera, H Kumano, K Nagamachi.   

Abstract

We report a case of 52-year-old woman with primary antiphospholipid syndrome who developed mitral insufficiency and chronic renal failure. Continuous ambulatory peritoneal dialysis was started preoperatively due to thrombocytopenia that was aggravated by hemodialysis. Mitral annuloplasty was performed since the mitral valve was not severely damaged. Her postoperative hemodynamics were stable, and anticoagulant therapy was controlled easily. She recovered from severe thrombocytopenia while on continuous ambulatory peritoneal dialysis. Valvular heart disease is a well known feature of primary antiphospholipid syndrome, and there have been several reports about valve replacement in patients who had antiphospholipid syndrome with or without systemic lupus erythematosus. However, valve repair has been reported in only a few such patients. We believe that valve repair is better than valve replacement in patients with antiphospholipid syndrome because of its hypercoagulable tendency. In addition, it seems that continuous ambulatory peritoneal dialysis is a suitable method for the perioperative management of patients with antiphospholipid syndrome who suffer from chronic renal failure as well as thrombocytopenia, and require cardiac surgery under cardiopulmonary bypass.

Entities:  

Mesh:

Year:  2001        PMID: 11305057     DOI: 10.1007/bf02913596

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  10 in total

1.  Plasma exchange for thrombocytopenia in antiphospholipid syndrome: a case report.

Authors:  A Satomi; F Koiwa; H Ogata; E Kinugasa; T Akizawa; T Ideura
Journal:  Ther Apher       Date:  1998-05

2.  Mitral valve plasty in systemic lupus erythematosus in the setting of antiphospholipid syndrome.

Authors:  M Yoshida; Y Sasako; J Kobayashi; K Minatoya; K Bando; S Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-06

3.  Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome.

Authors:  B Godeau; J C Piette; P Fromont; L Intrator; A Schaeffer; P Bierling
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 4.  Towards improved criteria for the antiphospholipid syndrome.

Authors:  J C Piette
Journal:  Lupus       Date:  1998       Impact factor: 2.911

5.  Aortic regurgitation progressing to aortic stenosis in antiphospholipid syndrome.

Authors:  A Escalante; F O Tio; G L Freeman
Journal:  Am Heart J       Date:  1995-10       Impact factor: 4.749

6.  Radial artery occlusion in primary antiphospholipid syndrome after aortic valve replacement.

Authors:  R A Asherson; A Weinberger; R H Kinsley
Journal:  S Afr Med J       Date:  1995-10

Review 7.  Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment.

Authors:  G Nesher; J Ilany; D Rosenmann; A S Abraham
Journal:  Semin Arthritis Rheum       Date:  1997-08       Impact factor: 5.532

8.  Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy.

Authors:  A J Hakim; S J Machin; D A Isenberg
Journal:  Semin Arthritis Rheum       Date:  1998-08       Impact factor: 5.532

9.  [Successful surgical treatment of mitral regurgitation associated with anti-phospholipid syndrome and systemic lupus erythematosus].

Authors:  S Noji; N Kitamura; T Miki; S Kimura; K Shunto; A Yamaguchi
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1995-08

Review 10.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

Authors:  M Hojnik; J George; L Ziporen; Y Shoenfeld
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

  10 in total
  1 in total

Review 1.  Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.

Authors:  Wobbe Bouma; Theo J Klinkenberg; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Marc Bijl; Albert J H Suurmeijer; Felix Zijlstra; Massimo A Mariani
Journal:  J Cardiothorac Surg       Date:  2010-03-23       Impact factor: 1.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.